SCHEMBL29133994

SCHEMBL29133994

CCCCCCCCCCCCCCCOCC(COP(=O)(O)OCCN)OCCCCCCCCCCCCCCC

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 1/20 0.73
LPAR1 Q92633 9/20 0.70
LPAR3 Q9UBY5 9/20 0.70
LPAR2 Q9HBW0 6/20 0.62
PLA2G2D Q9UNK4 1/20 0.54
TLR2 O60603 3/20 0.51
LPAR5 Q9H1C0 6/20 0.49
LPAR6 P43657 5/20 0.49
LPAR4 Q99677 5/20 0.49
P2RY10 O00398 2/20 0.48
AKT1 P31749 2/20 0.46
PLCG2 P16885 1/20 0.46
PIK3R1 P27986 1/20 0.46
AKT2 P31751 1/20 0.46
PIK3CA P42336 1/20 0.46
AKT3 Q9Y243 1/20 0.46
GAB1 Q13480 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28622692 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL29206151 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL28622690 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL23300849 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL2702607 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL25394384 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL931685 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL21568785 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL22092476 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D
SCHEMBL29692534 1.00 PLA2G2C (0.73) PLA2G2CLPAR1LPAR3LPAR2PLA2G2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117043343-A Nucleic acid vaccine for mutant coronaviruses 苏州艾博生物科技有限公司 2023-11-10 CN disclosed